FULZOS 250MG INJ

Product Description

• Active Ingredient: Fulvestrant 250 mg/5 ml solution for injection.
• Class: Estrogen receptor antagonist (an estrogen blocker) and antineoplastic drug.
• How it Works: Many breast cancers have estrogen receptors and depend on the hormone estrogen to grow. Fulvestrant works by binding to these estrogen receptors and blocking the action of estrogen on the cancer cells. This causes the receptors to degrade, slowing down or stopping the growth of the tumor cells. 

• Hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer.
• Cancer that has progressed after prior treatment with other anti-estrogen medications.
• It may be used alone (monotherapy) or in combination with other anti-cancer medications like palbociclib or abemaciclib